Form 4: BIODESIX CFO Reports Stock Transactions

BIODESIX CFO Robin Harper Cowie reported the acquisition of 158 common shares from RSU vesting and the sale of 50 shares to cover taxes, adjusted for a recent reverse stock split.

Summary

• Robin Harper Cowie, CFO, Secretary & Treasurer of BIODESIX INC (BDSX), reported transactions involving the company's common stock.
• On November 10, 2025, Cowie acquired 158 shares of common stock through the vesting of Restricted Stock Units (RSUs).
• Concurrently, 50 shares of common stock were sold at a price of $7.62 per share to cover tax obligations related to the RSU vesting.
• All reported share numbers have been adjusted to reflect a one-for-twenty reverse stock split that became effective on September 15, 2025.
• Following these transactions, Cowie beneficially owns 13,147 shares of common stock directly.
• The RSU vesting schedule involves sixteen successive quarterly installments, commencing from February 8, 2022, contingent on continued service.
• The reported beneficial ownership also includes 500 shares purchased under the company's Employee Stock Purchase Plan on September 2, 2025, adjusted for the reverse stock split.

Sentiment

Score: 5

Explanation: Neutral. This is a routine Form 4 filing reporting an insider's stock transactions, specifically RSU vesting and a tax-related sale. It does not indicate significant positive or negative sentiment about the company's performance or future prospects beyond the standard alignment of executive incentives.

Positives

• The vesting of Restricted Stock Units indicates continued long-term incentive alignment between management and shareholders.
• The acquisition of 158 shares through RSU vesting increases the CFO's direct ownership in the company.

Negatives

• The sale of 50 shares, while for tax purposes, represents a reduction in direct beneficial ownership.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: Provides transparency regarding executive stock ownership and compensation structure. The sale of shares for tax purposes is a common occurrence and generally not a significant concern.
• Employees: The RSU vesting and Employee Stock Purchase Plan participation highlight the company's incentive programs for employees, potentially impacting morale and retention.

Next Steps

• Continued vesting of remaining 157 Restricted Stock Units in successive quarterly installments.

Key Dates

Recommendation

This Form 4 filing details routine insider transactions related to RSU vesting and a subsequent tax-related sale. Such transactions are common and do not typically signal a change in the company's fundamental outlook or performance. The CFO's continued ownership, even with a small tax-related sale, maintains alignment with shareholder interests. Therefore, based solely on this filing, a "hold" recommendation is appropriate as there's no new information to warrant a change in investment thesis.

Keywords

BIODESIX, BDSX, Form 4, Insider Trading, Stock Transaction, CFO, Robin Harper Cowie, Restricted Stock Units, RSU Vesting, Reverse Stock Split, Employee Stock Purchase Plan